BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Clin Oncol. Nov 24, 2026; 17(11): 125117
Published online Nov 24, 2026. doi: 10.5306/wjco.125117
Development and internal validation of a disease-free survival model after radical resection of pathological T4 colorectal adenocarcinoma
Qing-Yuan Zeng, Xue-Lian Wu, Qian-Ru Hang, Rong-Peng Chen, Guo-Qiang Wang
Qing-Yuan Zeng, Xue-Lian Wu, Rong-Peng Chen, Guo-Qiang Wang, Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, Guangdong Province, China
Qian-Ru Hang, Jiangsu Province Key Laboratory of Anesthesiology and Brain Science, Xuzhou Medical University, Xuzhou 221004, Jiangsu Province, China
Co-first authors: Qing-Yuan Zeng and Xue-Lian Wu.
Co-corresponding authors: Rong-Peng Chen and Guo-Qiang Wang.
Author contributions: Zeng QY and Wu XL contributed equally to this work; Wang GQ and Chen RP designed the study; Chen RP, Zeng QY, and Wu XL collected and analyzed the data; Hang QR contributed to the statistical methodology and prepared the figures and tables; Zeng QY and Wu XL drafted the manuscript; Wang GQ and Chen RP critically revised the manuscript; Wang GQ reviewed the study methodology and findings; all authors interpreted the results, read and approved the final manuscript, and agree to be accountable for all aspects of the work. Wang GQ and Chen RP both contributed substantially to the study design and critical revision of the manuscript and share responsibility for the scientific content. Wang GQ additionally reviewed the study methodology and findings and serves as the contact for editorial correspondence.
AI contribution statement: ChatGPT was used solely for language refinement and improvement of the readability of the manuscript. All AI-generated suggestions were carefully reviewed and verified by the authors.
Institutional review board statement: The study was reviewed and approved by the Ethics Committee of The Second Affiliated Hospital of Guangzhou Medical University (Approval No. LYZX-2026-135-01).
Informed consent statement: The requirement for written informed consent was waived by the ethics committee because this retrospective study analyzed existing clinical data and involved no additional intervention.
Conflict-of-interest statement: All authors report no relevant conflicts of interest for this article.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: De-identified analytic data may be made available by the corresponding author upon reasonable request and subject to institutional approval.
Corresponding author: Guo-Qiang Wang, MD, Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Guangzhou Medical University, No. 250 Changgang East Road, Haizhu District, Guangzhou 510260, Guangdong Province, China. wgqjyh@126.com
Received: July 1, 2026
Revised: August 19, 2026
Accepted: October 22, 2026
Published online: November 24, 2026
Processing time: 140 Days and 21.5 Hours
Abstract
BACKGROUND

Postoperative outcomes vary substantially among patients with pathological T4 (pT4) colorectal adenocarcinoma despite radical resection. Pathological staging may not fully capture risk heterogeneity within this high-risk population.

AIM

To develop and internally validate a disease-free survival (DFS) prediction model after radical resection of pT4 colorectal adenocarcinoma.

METHODS

This single-center retrospective cohort included 440 of 690 patients screened from 2018 to 2022. Least absolute shrinkage and selection operator-Cox regression was used for predictor selection, followed by unpenalized Cox refitting in the full cohort. Conditional optimism correction used 1000 bootstrap resamples with selected terms fixed. Apparent time-dependent discrimination, calibration, and decision curves were evaluated at 36 months and 60 months. A TNM-only Cox comparator based on pT4 subtype and pN stage was used.

RESULTS

During a median follow-up of 51 months, 159 patients (36.1%) experienced a DFS event. Seven clinical variables represented by eight regression terms were retained. The apparent concordance index was 0.670 [95% confidence interval (CI): 0.628-0.711] and 0.652 after conditional optimism correction. Apparent time-dependent areas under the curve were 0.704 (95%CI: 0.650-0.756) at 36 months and 0.717 (95%CI: 0.644-0.780) at 60 months. The TNM-only comparator had apparent and conditional optimism-corrected C-indices of 0.609 and 0.598, respectively. Apparent calibration showed generally close agreement between predicted and observed risks, and decision curves suggested potential net benefit across portions of the evaluated threshold range.

CONCLUSION

The proposed model provided more detailed postoperative risk characterization than TNM staging alone, with moderate discrimination and reasonable apparent calibration. External validation is required before clinical use.

Keywords: Colorectal neoplasms; Disease-free survival; Prognostic model; Pathological T4; Nomogram; Internal validation

Core Tip: This single-center retrospective cohort study developed and internally validated a postoperative disease-free survival model for 440 patients with radically resected pathological T4 colorectal adenocarcinoma. Seven routinely available clinical and pathological variables were retained. The conditional optimism-corrected concordance index was 0.652, and the model showed higher discrimination than a TNM-only comparator within the development cohort. Apparent calibration was generally close, and decision-curve analysis suggested potential net benefit. The complete prediction equation and nomogram are provided. External validation and clinical-impact assessment are required before clinical use.

Write to the Help Desk